University of Pittsburgh
The goal of this study is to test a behavioral program for pregnant individuals with ADHD. This behavioral program focuses on skills for managing ADHD and related symptoms in pregnancy and postpartum. This pilot effectiveness-implementation trial aims to (1) preliminarily evaluate the MomMA behavioral intervention compared to treatment as usual (TAU) on clinical outcomes and (2) evaluate implementation outcomes, including feasibility and acceptability of clinic screening within existing OB workflows; assessment and intervention protocols; provider training/fidelity to manual; and all other study protocols from the perspective of real-world providers and participants.
Treating pregnant individuals with ADHD may improve parent and child wellbeing, parent-child interactions, and psychosocial familial factors to enhance family resilience and reduce prevalence/severity of child mental health disorders. The current study will test the MomMA (Moms Managing ADHD) intervention and implement it via a randomized controlled trial (N= 40 pregnant women with ADHD; 20 receiving the behavioral intervention and 20 receiving TAU), delivered by women's health behavioral therapists. Investigators will examine treatment acceptability, feasibility, and appropriateness, as well…
Inclusion Criteria: 1. meets full DSM-5 criteria for ADHD 2. is between 14- and 22-weeks of gestation 3. 18 years of age or older 4. English speaking 5. Lives in Pennsylvania Exclusion Criteria: 1. substance use disorders requiring dual diagnosis treatment 2. intellectual disability 3. bipolar disorder, psychosis, and major depressive disorder with suicidal ideation 4. the following high complexity medical conditions during pregnancy: maternal cancer, multiples, placenta accreta, and/or fetus known to have a severe congenital condition
The MomMA program is a CBT-based behavioral intervention with components targeted specifically towards expectant parents with ADHD. Treatment will be delivered by therapists embedded in OB care settings.
Participants will receive treatment as usual, including but not limited to medication and behavioral therapy. No participation in treatment is required.
Arctuva estimate
Verify or correct the compensation shown for this listing.